MedPage Today -- The FDA has approved liraglutide (Victoza), a once-daily injection of a glucagon-like peptide-1 (GLP-1) analogue, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
MedPage Today -- The FDA has approved liraglutide (Victoza), a once-daily injection of a glucagon-like peptide-1 (GLP-1) analogue, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.